4-Nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97%, 5g

4-Bromo-3-nitrobenzoic acid, 97.0%, 5g

5-Chloromethyl-3-(4-methylsulfanyl-phenyl)-[1,2,4]oxadiazole, 97.0%, 1g

7-Bromoquinoline-8-carboxylic acid, 95.0%, 5g

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine, 95.0%, 25g

N-methoxy-N-methyl-2-phenylacetamide, 95.0%, 5g

4-Chloro-5-methoxy-2,3-dihydro-1H-inden-1-one, 95.0%, 1g

Bilancia analitica e di precisione serie Entris® II Modelli con regolazione esterna, non certificata, 0,01 g, 820 g, BCE822-1S

N-[(4-Chloro-3-nitro-phenylcarbamoyl)-methyl]-N-cyclohexyl-3-nitro-benzamide, 98%, 1g

(S)-Methyl morpholine-3-carboxylate hydrochloride, 95.0%, 1g

2-(4-Bromo-3-nitrophenyl)acetic acid, 98%, 10g

6-CYANOINDOLE-1-ACETIC ACID, 97.0%, 250mg

4-(3,4-diethoxyphenyl)-1H-pyrazol-5-amine, 1g